Showing results (231-240 of 458) with videos related to
Sort By:
Pageof 46
JSES Reviews, Reports, and Techniques|March 20, 2026
Does pre-operative metabolic and nutritional assessment have greater association with perioperative complications than frailty following surgical intervention for proximal humerus fractures?Tyler K Williamson, Adam Aziz, Brooks Bluhm, et al.Journal of Medical Genetics|February 5, 2002
National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiologyD Morrison, D FitzPatrick, I Hanson, et al.Annals of Biomedical Engineering|May 24, 2018
Motile Dendritic Cells Sense and Respond to Substrate GeometryAmy C Bendell, Nicholas Anderson, Daniel Blumenthal, et al.JSES Reviews, Reports, and Techniques|February 7, 2024
Top 50 most impactful publications on massive rotator cuff tearsMarcheta Hill, Christian Allen, Tyler K Williamson, et al.Analytical Chemistry|May 13, 2022
Characterization and Sequence Mapping of Large RNA and mRNA Therapeutics Using Mass SpectrometryChristina J Vanhinsbergh, Angela Criscuolo, Jennifer N Sutton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420Stephen K Williamson, James Moon, Chao H Huang, et al.Cancer|June 1, 1993
Prolonged, alternating chemotherapy for extensive small cell lung cancer. A Southwest oncology Group studyR B Livingston, J J Crowley, T Thompson, et al.Investigational New Drugs|January 10, 2013
Preclinical antitumor activity of a nanoparticulate SN38Mazin F Al-Kasspooles, Stephen K Williamson, David Henry, et al.Biochimica Et Biophysica Acta|May 17, 1995
Lipids and oxidised lipids in human atherosclerotic lesions at different stages of developmentK L Carpenter, S E Taylor, C van der Veen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1991
Activity of esorubicin in recurrent malignant lymphoma: a Southwest Oncology Group studyT P Miller, S Dahlberg, S E Salmon, et al.Pageof 46